Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 42,983 | 50,041 | 20,165 | 0 | 0 |
| Gross Profit | 42,983 | 50,041 | 20,165 | N/A | N/A |
| Operating Expenses | 153,680 | 104,161 | 60,494 | 31,129 | 0 |
| Operating Income | -110,697 | -54,120 | -40,329 | -31,129 | N/A |
| Interest Expense | 71 | 106 | 116 | 103 | 0 |
| Other Income | 2,238 | 2,189 | -1,344 | 105 | 0 |
| Pre-tax Income | -108,530 | -52,037 | -41,789 | -31,127 | 0 |
| Income Tax | -371 | -4,373 | N/A | N/A | N/A |
| Net Income Continuous | -108,159 | -47,664 | -41,789 | -31,127 | N/A |
| Net Income | $-108,159 | $-47,664 | $-41,789 | $-31,127 | $N/A |
| EPS Basic Total Ops | -2.01 | -22.33 | -21.24 | -20.25 | N/A |
| EPS Basic Continuous Ops | -1.97 | -17.19 | -18.18 | -18.07 | N/A |
| EPS Diluted Total Ops | -2.01 | -22.33 | -21.24 | -20.25 | N/A |
| EPS Diluted Continuous Ops | -1.97 | -17.19 | -18.18 | -18.07 | N/A |
| EPS Diluted Before Non-Recurring Items | -2.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-103,184 | $-51,228 | $-38,565 | $-29,941 | $N/A |